Branched Stent Grafts Market Size, Share & Trends Analysis Report By Type (Iliac Stent, Others), By Applications (EVAR, Chimney, Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Branched Stent Grafts Market Size

The global branched stent grafts market size was valued at USD 376.28 million in 2025 and is projected to grow from USD 405.25 million in 2026 to USD 733.59 million by 2034, registering a CAGR of 7.7% during the forecast period from 2026 to 2034. North America dominated the branched stent grafts market with a market share of 39.2% in 2025.

The advantages of minimally invasive procedures have resulted in a significant rise in their adoption, thereby propelling the market. Branched stent grafts are state-of-the-art medical devices used in thoracoabdominal aortic pathologies and aortic aneurysms during endovascular procedures. These devices comprise multiple branches that reach the targeted arteries and a primary stent graft that is inserted into the aorta. Branched stent grafts allow blood flow redirection by offering a scaffold-like structure, effectively treating the diseased area and reducing the risk of complications. The purpose of the branched stent graft is to treat aortic lesions. It will be utilized in the extracorporeal balloon aortic dissection and EVAR of pectoral aneurism, extending its application from the aorta to each aorta.

Type Insights

The global branched stent grafts market is categorized into iliac stents and others. The iliac stent segment dominates the global market and is expected to exhibit a CAGR of 6.1% during the forecast period. One of the main drivers of the global market expansion for iliac stents is the rise in the prevalence of cardiovascular illnesses. Similarly, rapid technological improvements and widespread acceptance of stenting operations are anticipated to fuel segment expansion. On the other hand, the availability of alternative treatment options and the increasing number of product recalls may hinder the market growth. Moreover, the iliac artery's blood flow becomes blocked due to the thicker blood vessel wall narrowing. In 2018, around 58% of deaths due to aortic aneurysms occurred among men in the U.S. Such factors propel segment growth.

Furthermore, numerous market players are offering iliac stents in the market. Some of them are Alvimedica, Biotronik, Medtronic, and Endocor. These players constantly contribute to market growth through initiatives such as launching new products and mergers and acquisitions. For instance, in July 2019, Terumo Corporation introduced MISAGO RX Self-expanding Peripheral Stent for use in iliac arteries.

Request Customizationto receive a tailored report.

Application Insights

The global branched stent grafts market is categorized into Endovascular Aneurysm Repair (EVAR), Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR), chimney, and others. The EVAR segment owns the highest market share and is anticipated to exhibit a CAGR of 7.7% during the forecast period. Endovascular Aneurysm Repair (EVAR) held the largest market share of other segments during the forecast period. Patient demand for endovascular aortic repair procedures is rapidly growing across the globe. In the United States, endovascular stent grafts are currently the preferred treatment for up to 80% of aortic aneurysm cases. This is expected to promote market growth.

Endovascular aortic repair has become the foremost technique for treatment, accounting for over 77% of aortic repairs in 2019. The technique was developed in 1990. This procedure has undergone radical changes in efficacy over the past decade owing to improvements in graft technology and manufacturing techniques. Moreover, EVAR is a chosen treatment option for aortic aneurysms owing to its advantages over open surgical treatment. These advantages comprise shorter hospital stays, minimally invasive, quick recovery time, and enhanced patient outcomes. This is expected to boost the segment growth.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global branched stent grafts market shareholder and is anticipated to exhibit a CAGR of 7.51% during the forecast period. This can be attributed to the area's important players, reimbursement coverage, and well-established healthcare infrastructure. The growing burden of vascular diseases is boosting the need for minimally invasive procedures, further fueling the growth of the branched stent graft market in the region. The number of procedures in the region is rising due to the steadily increasing target patient population and the rapidly aging population. Moreover, the regional market is competitive with the presence of major market players. Companies such as Abbott, Cook, and Cordis are adopting various strategies to maintain their market share. For instance, in October 2018, Medtronic received FDA approval for the Valiant Navion Thoracic Stent Graft System.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Branched Stent Grafts Market Trends

Europe is estimated to grow at a CAGR of 7.4% during the forecast period. The existence of developed economies, high disposable income, and the availability of well-established healthcare infrastructure and qualified professionals all contribute to the market's growth. The increasing elderly population, rising expenditure on healthcare, and growing awareness about minimally invasive procedures are among the factors positively influencing market growth. The growing burden of peripheral arterial disease is expected to boost market growth. This is one of the key factors supporting the market growth.

Moreover, numerous stent manufacturers have been boosting product penetration in the region and have been able to leverage considerable opportunities. Europe's branched stent graft market is expected to grow in the coming years, owing to advancements in branched stent technology.

Asia Pacific Branched Stent Grafts Market Trends

Asia-Pacific is the third largest region. The Asia Pacific branched stent graft market is anticipated to hold a market share of 19.88% in 2021, owing to rising spending on healthcare and growing medical tourism in the region. Developing countries like China, Japan, India, and Australia are included in the region. The expansion of the market has been driven by these nations' more convenient, cost-effective treatment options and higher-caliber healthcare infrastructure. Moreover, increasing awareness among people in developing countries is boosting the demand for branched stent graft market.

Furthermore, Australia has substantially developed minimal image-guided therapy and technology for managing aortic aneurysm disease. There has been continual attention and support for progress from all sectors in Australia, ranging through government regulatory bodies, clinicians, hospital administration, medical device companies, and scientific research organizations. Around 2,000 aneurysms are repaired annually by endovascular techniques in Australia and New Zealand. Moreover, the Australian and New Zealand Society for Vascular Surgery is now accountable for guiding vascular surgeons. These factors are expected to support the market growth.

List of Key and Emerging Players in Branched Stent Grafts Market